Back to Search
DEAN POLLOCK, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1700880259Individual
Specialties, Licenses & Credentials
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
0101039339(VA)
Research & Publications (20)
Does targeting the lipophilic milieu provide advantages for an endothelin antagonist?
PMID 19401539·Mol Interv·2009
7-preclinical
How does endothelin induce vascular oxidative stress in mineralocorticoid hypertension?
PMID 16323976·Clin Sci (Lond)·2006
7-preclinical
Endothelin and oxidative stress in the vascular system.
PMID 16248780·Curr Vasc Pharmacol·2005
6-review
Endothelin, angiotensin, and oxidative stress in hypertension.
PMID 15723961·Hypertension·2005
6-review
L-type calcium channels in the renal microcirculatory response to endothelin.
PMID 15547114·Am J Physiol Renal Physiol·2005
7-preclinical
Endothelin antagonists in the treatment of renal failure.
PMID 11566009·Curr Opin Investig Drugs·2001
6-review
Evidence for endothelin involvement in the response to high salt.
PMID 11399655·Am J Physiol Renal Physiol·2001
4-observational
A clinically practical method of manually assessing polyethylene liner thickness.
PMID 11741058·J Bone Joint Surg Am·2001
8-other
Contrasting pharmacological ETB receptor blockade with genetic ETB deficiency in renal responses to big ET-1.
PMID 11395545·Physiol Genomics·2001
4-observational
Combined effects of AT(1) and ET(A) receptor antagonists, candesartan, and A-127722 in DOCA-salt hypertensive rats.
PMID 11368889·Gen Pharmacol·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7544 Medical Dr Ste 202
Gloucester, VA 23061 - Phone
- (804) 694-5553
Quick Facts
- NPI
- 1700880259
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile